ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
•27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
439 Views
Share
bullish•WuXi AppTec
•21 Nov 2018 10:41

Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe

WuXi Apptec is set to be the newest A/H pair with its upcoming HK listing that is set to raise USD 1 billion. The A-share (603289 CH) recorded 15...

Share
•18 Nov 2018 19:05

Smartkarma's Week in JP/KR: SoftbankCorp IPO, Toshiba, J-Banks, Wafers/Semi, Hanjin Kal, BioLogics

This past week featured 165 insights across the Smartkarma platform, with about 25% of them dealing with Japan or South Korea.  A list is below.By...

Logo
484 Views
Share
bullish•Samsung C&T
•15 Nov 2018 08:12

Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T

The FSC said it had found intentionality behind BioLogics’ breach of accounting rules. Hence, the FSC pressed criminal charges against BioLogics...

Logo
602 Views
Share
bearish•Samsung Biologics
•14 Nov 2018 17:09

Samsung Biologics: A Temporary Suspension of Shares Trading

The Korean financial regulators announced a temporary suspension of shares trading for Samsung Biologics Co., (207940 KS) as of today, mainly due...

Logo
610 Views
Share
x